Market overview
The global safety syringe market is worth USD 4.5 bn in 2026 and is forecast to reach USD 9.8 bn by 2036, growing at a 8.0% CAGR. United States is the largest country market and Manual sliding shield is the largest by mechanism segment.
| Scope | Syringes with a built-in needle shield, retractable needle or auto-disable lock to prevent needlestick injury and reuse, including safety prefilled syringes. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 4.2 bn |
| Value 2026 | USD 4.5 bn |
| Value 2036 | USD 9.8 bn |
| CAGR 2026-2036 | 8.0% |
| Volume 2026 | 12,896 million units |
| Volume 2036 | 26,486 million units |
| Average price 2026 | USD 0.35 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Safety Syringe market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 4.5 bn |
| 2027 | USD 4.9 bn |
| 2028 | USD 5.3 bn |
| 2029 | USD 5.7 bn |
| 2030 | USD 6.2 bn |
| 2031 | USD 6.7 bn |
| 2032 | USD 7.2 bn |
| 2033 | USD 7.8 bn |
| 2034 | USD 8.4 bn |
| 2035 | USD 9.1 bn |
| 2036 | USD 9.8 bn |
Safety Syringe market segmentation
By mechanism
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Manual sliding shield | 30.0% | 27.2% | USD 1.4 bn | 6.9% |
| Retractable needle | 30.0% | 31.2% | USD 1.4 bn | 8.4% |
| Auto-disable | 22.0% | 18.1% | USD 998 mn | 5.9% |
| Passive shielded prefilled | 18.0% | 23.5% | USD 816 mn | 10.9% |
By application
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Vaccination | 28.0% | 23.2% | USD 1.3 bn | 6.0% |
| Therapeutic injection | 36.0% | 39.5% | USD 1.6 bn | 9.0% |
| Diabetes | 14.0% | 15.3% | USD 635 mn | 9.0% |
| General use | 22.0% | 22.0% | USD 998 mn | 8.0% |
By volume
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Up to 1 ml | 44.0% | 45.0% | USD 2.0 bn | 8.2% |
| 2 to 5 ml | 36.0% | 34.0% | USD 1.6 bn | 7.4% |
| Above 5 ml | 20.0% | 21.0% | USD 907 mn | 8.5% |
By safety feature
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Needle shield | 44.0% | 40.0% | USD 2.0 bn | 7.0% |
| Retractable needle | 30.0% | 32.0% | USD 1.4 bn | 8.7% |
| Auto-disable | 26.0% | 28.0% | USD 1.2 bn | 8.8% |
By buyer
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 44.0% | 42.0% | USD 2.0 bn | 7.5% |
| Mass immunisation programs | 26.0% | 26.0% | USD 1.2 bn | 8.0% |
| Clinics and pharmacies | 20.0% | 22.0% | USD 907 mn | 9.0% |
| Home users | 10.0% | 10.0% | USD 454 mn | 8.0% |
Top 25 countries for safety syringe by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 76.5% of 2026 revenue and the 25 countries below together hold 93.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 1.5 bn | 34.0% | USD 3.1 bn | 7.1% |
| 2 | India | USD 318 mn | 7.0% | USD 911 mn | 11.1% |
| 3 | China | USD 318 mn | 7.0% | USD 911 mn | 11.1% |
| 4 | Germany | USD 272 mn | 6.0% | USD 509 mn | 6.5% |
| 5 | Japan | USD 227 mn | 5.0% | USD 392 mn | 5.6% |
| 6 | France | USD 181 mn | 4.0% | USD 343 mn | 6.6% |
| 7 | United Kingdom | USD 181 mn | 4.0% | USD 343 mn | 6.6% |
| 8 | Brazil | USD 159 mn | 3.5% | USD 382 mn | 9.2% |
| 9 | Italy | USD 136 mn | 3.0% | USD 255 mn | 6.5% |
| 10 | Indonesia | USD 136 mn | 3.0% | USD 392 mn | 11.2% |
| 11 | Mexico | USD 132 mn | 2.9% | USD 285 mn | 8.0% |
| 12 | Spain | USD 104 mn | 2.3% | USD 181 mn | 5.7% |
| 13 | Russia | USD 77 mn | 1.7% | USD 133 mn | 5.6% |
| 14 | Pakistan | USD 62 mn | 1.4% | USD 153 mn | 9.4% |
| 15 | Turkey | USD 53 mn | 1.2% | USD 129 mn | 9.4% |
| 16 | Egypt | USD 46 mn | 1.0% | USD 113 mn | 9.4% |
| 17 | Vietnam | USD 41 mn | 0.9% | USD 101 mn | 9.5% |
| 18 | South Africa | USD 37 mn | 0.8% | USD 91 mn | 9.5% |
| 19 | Thailand | USD 34 mn | 0.8% | USD 83 mn | 9.4% |
| 20 | Nigeria | USD 31 mn | 0.7% | USD 77 mn | 9.5% |
| 21 | Poland | USD 29 mn | 0.6% | USD 71 mn | 9.4% |
| 22 | Bangladesh | USD 27 mn | 0.6% | USD 67 mn | 9.4% |
| 23 | Philippines | USD 26 mn | 0.6% | USD 63 mn | 9.3% |
| 24 | Argentina | USD 24 mn | 0.5% | USD 60 mn | 9.3% |
| 25 | Saudi Arabia | USD 23 mn | 0.5% | USD 57 mn | 9.4% |
| Rest of world | USD 319 mn | 7.0% | USD 638 mn | 7.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- BD
- Terumo
- B. Braun
- Cardinal Health
Group 2: Regional and specialist players
- Retractable Technologies
- Nipro
- Hindustan Syringes & Medical Devices
- Shandong Weigao Group
- Poly Medicure
- HTL-Strefa
- Narang Medical
Group 3: Emerging and niche players
- UltiMed
- Sol-Millennium
- Jiangxi Hongda Medical Equipment
- Zhejiang Kindly Medical Devices
- Advin Health Care
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the safety syringe market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 8.0% is calculated from the resulting values.
The market is divided by mechanism, by application, by volume, by safety feature, by buyer. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the safety syringe market?
The global safety syringe market is estimated at USD 4.2 bn in 2025 and USD 4.5 bn in 2026.
How fast will the safety syringe market grow?
It is forecast to reach USD 9.8 bn by 2036, a compound annual growth rate of 8.0% from 2026, an increase of USD 5.3 bn.
Which country is the largest market for safety syringe?
United States is the largest market by revenue at USD 1.5 bn in 2026, 34.0% of the global total. The three largest countries together hold 48.0%.
Which country is growing fastest?
Among the ten largest markets, Indonesia is growing fastest at 11.2% a year from 2026 to 2036.
Which safety syringe segment is largest?
In the by mechanism split, Manual sliding shield is the largest segment with 30.0% of 2026 revenue.
Who are the leading safety syringe companies?
Global leaders include BD, Terumo, B. Braun, Cardinal Health.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Aseptic FillingUSD 4.8 bn · 8.0% CAGR
- Lower Limb Arterial Disease ManagementUSD 4.1 bn · 7.2% CAGR
- Nuclear MedicineUSD 4.0 bn · 6.2% CAGR
- Behavioral Health Continuum SolutionsUSD 4.0 bn · 10.5% CAGR
- LiposomeUSD 5.2 bn · 8.0% CAGR
- Patient RecruitmentUSD 5.2 bn · 9.0% CAGR
- Biospecimen LogisticsUSD 3.9 bn · 9.0% CAGR
- Sterile Single-Use Endoscopy AccessoriesUSD 5.4 bn · 7.5% CAGR